Death Clock promises to predict when you're going to die and help you extend your time on Earth. After a month, I felt like it was sucking the life out of me. I am scheduled to die on August 10, 2060, at the age of 74. So says my iPhone screen, where Death Clock, an AI -powered longevity app that predicts life expectancy based on your medical habits and lifestyle, has produced an image of a smiling grim reaper to celebrate my expiration date. There he was one September morning, looking especially thrilled about the reveal, gesturing with a peace sign as he reclined in a doughnut-shaped pool inflatable under that giant number: 74. I have never resented getting older, but I suppose that's younger than I'd like to be when my time is up.

Our gifting experts are obsessively searching for holiday gifts that are unique, thoughtful and suitable for any budget. Insulin resistance and blood pressure trends are now available on two new Fitbit devices. Nina Raemont is ZDNET's Health and Wearables Editor based in New York City. Insulin resistance and blood pressure trends are coming to the Fitbit Air and Fitbit Edge. These new features are available for Google Health Premium users only.

In unraveling the pathways by which movement helps the body, we could develop medicines that offer some of the same benefits, without the workout. We all know exercise is good for us. It builds muscle, strengthens bones, lowers blood pressure, and boosts mood. By deciphering how movement benefits the body, researchers hope to develop medicines that can offer some of the same perks--without the workout. The idea isn't to replace exercise but to bring its upsides to people who struggle with frailty, disability, or chronic illness. It will take a lot of experimentation to untangle the myriad pathways by which exercise promotes health.

You're viewing the US edition You can switch to the UK, AU or IE homepage at any time using this menu. Trump snaps at reporter in Oval Office skirmish: 'What's wrong with you?' Leaked Noah Presgrove filing makes explosive claims about alleged lover's plot to kill Oklahoma teen hours before his naked body was found on remote road next to his teeth'Cornell 7' frat boy's powerful family dynasty and web of connections to global elite revealed... as his own sister's fight against university rape emerges The pro-cellulite brigade thundered down the runway and ruined Victoria's Secret... here's what ordinary women really think of the brand's reboot: CAROLINE BULLOCK America's most popular baby names for 2026 revealed My fisherman friend, 71, was killed by an alligator after he'stole' its dinner. He saw it coming and tried to run... then slipped at the worst possible moment Prince and Princess of Wales dazzle as they join King hosting Sultan of Oman at glittering State Banquet - with royals bidding to put'distraction' of Harry's latest interview behind them So many single men are taking this new drug cocktail before dates. The results in the bedroom are startling... as I discovered during one marathon session: JANA HOCKING Menopause left me with thinning, wispy hair - and it shattered my confidence. Kim Zolciak's spiral caught on bodycam... as humiliating itemized dossier lays bare outrageous alleged indulgences and spending habits including eye-watering sums spent on her new face Kylie Jenner causes catfight backstage at Victoria's Secret show: Supermodels who couldn't hide their rage over her $50m Fantasy Bra... as Kris Jenner's secret deal to get her on runway is exposed I'm a Christian leader who attended a secret meeting with Anthropic.

You're viewing the US edition You can switch to the UK, AU or IE homepage at any time using this menu. Trump snaps at reporter in Oval Office skirmish: 'What's wrong with you?' Leaked Noah Presgrove filing makes explosive claims about alleged lover's plot to kill Oklahoma teen hours before his naked body was found on remote road next to his teeth'Cornell 7' frat boy's powerful family dynasty and web of connections to global elite revealed... as his own sister's fight against university rape emerges The pro-cellulite brigade thundered down the runway and ruined Victoria's Secret... here's what ordinary women really think of the brand's reboot: CAROLINE BULLOCK America's most popular baby names for 2026 revealed My fisherman friend, 71, was killed by an alligator after he'stole' its dinner. He saw it coming and tried to run... then slipped at the worst possible moment Prince and Princess of Wales dazzle as they join King hosting Sultan of Oman at glittering State Banquet - with royals bidding to put'distraction' of Harry's latest interview behind them So many single men are taking this new drug cocktail before dates. The results in the bedroom are startling... as I discovered during one marathon session: JANA HOCKING Menopause left me with thinning, wispy hair - and it shattered my confidence. Kim Zolciak's spiral caught on bodycam... as humiliating itemized dossier lays bare outrageous alleged indulgences and spending habits including eye-watering sums spent on her new face Kylie Jenner causes catfight backstage at Victoria's Secret show: Supermodels who couldn't hide their rage over her $50m Fantasy Bra... as Kris Jenner's secret deal to get her on runway is exposed I'm a Christian leader who attended a secret meeting with Anthropic.

After four weeks of using the cream, participants lowered the biological age of their skin by about two years on average. A wave of biotech companies is looking to prove that it's possible to slow down the aging process. Mountain View, California-based Rubedo Life Sciences is starting with the most outwardly visible sign: the skin. The company's experimental treatment is showing early promise that it may be able to reduce the appearance of aging, according to data the company presented at the Aging Research and Drug Discovery meeting in Boston earlier this month. In a small clinical trial, Rubedo tested its topical cream on 11 people with atopic dermatitis, an inflammatory skin condition and the most common type of eczema.

Plus: The US has frozen green cards for Microsoft and other IT firms. We're putting too much faith in AI's ability to say no Today's AI models are trained to refuse a vast number of prompts. If you ask your chatbot how to poison a colleague or how to tie a noose, chances are it'll turn you down. But refusal fails, sometimes horrifically. Some people are attempting to use AI to hone biological pathogens and build autonomous drone swarms. Sooner or later, failed refusals may result in global calamity.

Plus: OpenAI has released 377 new math findings, further rattling the field. Popular weight-loss drugs may do more than help people shed pounds. They might also slow the aging process. Drugmakers Eli Lilly and Novo Nordisk say patients taking their GLP-1 drugs age less quickly, according to molecular "aging clocks" that track changes in DNA or levels of key proteins. The findings add to speculation that GLP-1 drugs could be acting on basic causes of aging and might be true longevity treatments. But how much can we read into these results?

In a series of interviews, we're meeting some of the PhD students that were selected to take part in the Doctoral Consortium at the International Joint Conference on Artificial Intelligence and the 29th European Conference on Artificial Intelligence (IJACI-ECAI 2026) . This time, we hear from Mayra Elwes about her work developing machine learning methods for clinical time-series data. Tell us a bit about your PhD - where are you studying, and what is the topic of your research? I am a second-year computer science PhD student at the Institute for Biomedical Informatics at the University Hospital Cologne. My research focuses on the generalisation and domain adaptation of machine learning for clinical time-series forecasting, especially for clinic-to-clinic generalization scenarios.

The US resurgence of measles is forcing hospitals and health systems to adopt new protocols and procedures to deal with a disease they thought was in the past. John Goldman had not seen a case of measles in 30 years. But since April, the infectious disease specialist with the University of Pittsburgh Medical Center in central Pennsylvania has had dozens of patients come down with the disease. "I never thought I would see this come back," he says. His health system, like others, has had to adapt to a new normal as measles makes a comeback in the United States.